OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 28 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$298,000,000
+20.2%
55,400
+70.5%
0.01%
+25.0%
Q4 2015$248,000,000
-52.7%
32,500
-34.6%
0.00%
-55.6%
Q4 2014$524,000,00049,7000.01%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,340,588$2,440,0000.40%
ArrowMark Colorado Holdings LLC 942,059$1,715,0000.03%
A.R.T. Advisors, LLC 39,100$71,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 52,432$95,0000.02%
Orbimed Advisors 567,600$1,033,0000.01%
TWO SIGMA SECURITIES, LLC 15,697$29,0000.01%
Palo Alto Investors LP 63,517$116,0000.01%
Virtu KCG Holdings LLC 90,063$164,0000.00%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 10,000$18,0000.00%
FRANKLIN RESOURCES INC 2,182,185$3,972,0000.00%
View complete list of MARINUS PHARMACEUTICALS INC shareholders